Template:Androgen/anabolic steroid dosages for breast cancer
<
Template:Androgen
Route | Medication | Form | Dosage | Refs |
---|---|---|---|---|
Oral | Methyltestosterone | Tablet | 30–200 mg/day | [1][2][3][4] |
Fluoxymesterone | Tablet | 10–40 mg 3x/day | [1][5][6][7] | |
Calusterone | Tablet | 40–80 mg 4x/day | [1][7] | |
Normethandrone | Tablet | 40 mg/day | [2] | |
Buccal | Methyltestosterone | Tablet | 25–100 mg/day | [4] |
SC ) |
Testosterone propionate | Oil solution | 50–100 mg 3x/week | [1][2][8][6][7] |
Testosterone enanthate | Oil solution | 200–400 mg 1x/2–4 weeks | [9][10] | |
Testosterone cypionate | Oil solution | 200–400 mg 1x/2–4 weeks | [10][11] | |
Mixed testosterone esters |
Oil solution | 250 mg 1x/week | [6] | |
Methandriol | Aqueous suspension | 100 mg 3x/week | [8][11] | |
Androstanolone (DHT) | Aqueous suspension | 300 mg 3x/week | [2][8][12][11] | |
Drostanolone propionate | Oil solution | 100 mg 1–3x/week | [1][2][7] | |
Metenolone enanthate | Oil solution | 400 mg 3x/week | [7] | |
Nandrolone decanoate | Oil solution | 50–100 mg 1x/1–3 weeks | [13][14][15] | |
Nandrolone phenylpropionate | Oil solution | 50–100 mg/week | [16][7] | |
Note: Dosages are not necessarily equivalent. |
Template documentation
See also
- Template:Estrogen dosages for breast cancer
- Template:Estrogen dosages for prostate cancer
- Template:Androgen replacement therapy formulations and dosages used in women
- Template:Clinical dosage ranges of oral and injectable androgens and anabolic steroids
References
- ^ ISBN 978-0-8493-5973-6.
- ^ ISBN 978-3-642-65806-8.
- ^ "Android® C-III" (PDF). Valeant Pharmaceuticals North America. U.S. Food and Drug Administration.
- ^ ISBN 978-1-4200-4744-8.
- ISBN 978-0-7817-7328-7.
- ^ ISBN 978-3-642-86282-3.
- ^ ISBN 978-0-12-137250-7.
- ^ .
- ^ "DELATESTRYL® CIII (Testosterone Enanthate Injection, USP)" (PDF). U.S Food and Drug Administration.
- ^ ISBN 978-0-89970-160-8.
TESTOSTERONE CYPIONATE [Andro-Cyp, Depo-Testosterone, T-Ionate-P.A.] TESTOSTERONE ENANTHATE [Andryl, Delatestryl] These long-acting, potent esters of testosterone can maintain the testosterone level within the normal range in males for two to four weeks. [...] For metastatic breast carcinoma in women, 200 to 400 mg every two or more weeks.
- ^ PMID 14182428.
- S2CID 10089663.
- ^ "DECA-DURABOLIN (nandrolone decanoate)" (PDF). Archived from the original (PDF) on 2019-03-09.
- ^ "DECA-DURABOLIN" (PDF). New Zealand Data Sheet. Archived from the original (PDF) on 2018-01-28.
- ISBN 978-1-4377-1035-9.
- ISBN 978-1-4899-3067-5.